Home › NDC Lookup › RxCUI directory › RxCUI 261335

Levetiracetam 250 MG Oral Tablet [Keppra] — RxCUI 261335

RxNorm drug concept · Semantic branded drug
RxCUI 261335 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI261335
Official nameLevetiracetam 250 MG Oral Tablet [Keppra]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKeppra 250 MG Oral Tablet
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)25,605 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levetiracetam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats seizures in epilepsy. Depending on the product, that means partial-onset seizures, and as add-on therapy, myoclonic seizures in juvenile myoclonic epilepsy and primary ge...
  • Follow your prescriber and label. Tablets and solution are usually twice daily, while extended-release tablets are once daily and must be swallowed whole. Use a calibrated device f...
  • Sleepiness, tiredness, dizziness and headache are common, especially early on. Children may become irritable or aggressive. Avoid driving until you know how it affects you.
  • Call right away for new or worsening depression, suicidal thoughts, unusual behavior, a rash, swelling of the face or throat, or trouble walking. Get emergency help for trouble bre...
📖 Read our full Levetiracetam guide →

🕸️ Concept Web — How Levetiracetam 250 MG Oral Tablet [Keppra] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levetiracetam 250 MG Oral Tablet [Keppra] RxCUI 261335

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levetiracetam 114477
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Keppra 261547
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levetiracetam Oral Tablet 374617
    • Levetiracetam Oral Product 1163451
    • Levetiracetam Pill 1163452
    • Levetiracetam Oral Tablet [Keppra] 368212
    • Keppra Oral Product 1170054
    • Keppra Pill 1170055
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levetiracetam 250 MG Oral Tablet SCD · 311288
  • Levetiracetam 250 MG SCDC · 330791
  • Levetiracetam Oral Tablet SCDF · 374617
  • Levetiracetam Oral Product SCDG · 1163451
  • Levetiracetam Pill SCDG · 1163452

Brand-Name Concepts

  • Levetiracetam 250 MG [Keppra] SBDC · 574555
  • Levetiracetam Oral Tablet [Keppra] SBDF · 368212
  • Keppra Oral Product SBDG · 1170054
  • Keppra Pill SBDG · 1170055
  • Keppra BN · 261547

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 261335 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50474-0001-48 473 mL in 1 BOTTLE, PLASTIC (50474-001-48) Keppra UCB, Inc. 2003-10-20
50474-0594-40 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-594-40) Keppra UCB, Inc. 2000-04-24
50474-0595-40 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-595-40) Keppra UCB, Inc. 2000-04-24
50474-0596-40 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-596-40) Keppra UCB, Inc. 2000-04-24
50474-0597-66 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-597-66) Keppra UCB, Inc. 2000-04-24
Observed labelers: UCB, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.